Compare Ginkgo Bioworks Holdings Inc (DNA) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Paychex, Inc. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Paychex, Inc. trades at $121.11 (market cap $43.14B). The key difference: Paychex, Inc. is far larger — about 85.3× Ginkgo Bioworks Holdings Inc's market cap, and Paychex, Inc. pays a 3.92% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | PAYX | |
|---|---|---|
Market Cap | $505.73M | $43.14B |
Sector | Health | Industrials |
52-Week High | $16.14 | $140.81 |
52-Week Low | $5.48 | $85.57 |
Enterprise Value | $607.68M | $46.63B |
Dividend Yield | — | 3.92% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
